Abstract. Uveal melanoma is the most frequent primary intraocular tumor in the adult population. This malignancy has a high mortality rate and responds poorly to existing chemotherapy. Recently, the tumor environment has been found to exert a profound influence on drug response through cell interaction with components from the extracellular matrix (ECM). In the present study, wc investigated whether individual components from the ECM may affect cell survival and/or cell death induced by the cytotoxic agent cisplatin on the SP6.5 uveal melanoma cell line. Tumor cells were shown by immunofluorescence analyses to be surrounded by the ECM proteins fibronectin (FN), type IV collagen (CIV) and laminin (LM). both at the primary and metastatic sites. Binding of SP6.5 cells lo FN. LM and CIV is primarily dictated by the expression of membrane bound integrins from the Bl family as revealed by cell adhesion assays conducted on ECM-coated culture plates. Analysis of cell death by flow cytometry demonstrated that culluring SP6.5 cells in the presence of FN. CIV and LM. substantially reduced the percentage of cells undergoing apoplosis after cisplatin treatment when compared with those seeded on a nonpermissive matrix. These results suggest that adhesion of the SP6.5 uveal melanoma cells to the ECM proteins FN. CIV and LM might therefore confer resistance to the chemoiherapeulic agent cisplatin. The cellular resistance induced by the ECM proteins toward cisplatin could explain in part the local recurrence of metastasis derived from uveal melanoma often observed clinically after chemotherapy.
Introduction
Uveal melanoma is the most common type of primary intra ocular tumor in the adult population (I). This malignancy is remarkable for ils haematogenous dissemination, its unpredictable clinical course and its high tendency lo meta stasize primarily lo ihc liver (2.3). often alter a long diseaselice interval (4) . Chemotherapy remains the mainstay for the treatment of disseminated cancers including haemalologic malignancies and metastatic solid tumors (5) . Despite new treatments for primary uveal melanoma that have emerged over the past lew years, the survival rale has remained unchanged (3) . Metastatic uveal melanoma lesions appear to be highly resistant to most available chemolherapeutic agents presently available for the treatment of various malignancies as well as those established for the therapy of cutaneous melanoma (4.6) . The use of the BOLD chemotherapy regimen (dacarbazinc. lomustine. vincristine and bleomycin) combined with interferon-« was shown in the European Organization for Research and Treatment of Cancel-(EORTC) multicentre Study to be ineffective, despite encouraging data from the initial scries (4.7). For metastatic tliscasc localized to the liver, inlra-arlcrial injcclions of fotemustine or earboplalin. or chcmoembolizalion with cisplalin (cis-dichlorodiamminc plalinum". cDDP) report a response rale of 29-40% and a median overall survival of 6-18 months (4. [6] [7] [8] . Even if impressive initial responses lo chemotherapy are seen in a significant number of patients, residual and recurrent disease refractory lo further treatment could results in tumor relapse (9) . Even today, ihc problem of multidrug resistance (MDR). either by intrinsic or acquired mechanisms, still remains a major obstacle preventing cures of many forms of cancers (5) . Expression of the MDR I gene, encoding for the efflux pump P-glycoprotein. appears to be involved in the chemorcsisiancc of primary uveal melanoma (10) . Other classical mechanisms of MDR. such as glutaihionc-S-transfcrase upregulation and topoisomcrase II mutation or downregulation (8) have not been described in uveal melanoma.
Recently, evidence has accumulated suggesting that ihc direct interaction of cancer cells with components from their microenvironment may influence cancer cells response lo chemotherapy (5) . Indeed, interactions between cell surface iniegrins and ECM components have been shown to account for this phenomenon of innate drug resistance termed cell adhesion medialed-drug resistance, or CAM-DR (II).
It is well recognized that loss of cell-cell or ccll-ECM adhesion that lead to cell death, which is identified as anoikis. regulates apoptosis and cell survival in a wide variety of primary and transformed cells (12.13) . Furthermore, many forms of cancer chemotherapy primarily exert their cytotoxic effects by inducing apoptosis (9.1 1.14). For example, adhesion of cells to the ECM component LM resulted in an increased resistance to chemotherapy-induced apoptosis in small-cell lung cancer (15) . It has been shown that vitronectin, bul not FN, two other well-known components from the ECM. protects human glioma cell lines against etoposide-induced death (16) .
Very little is known about the function of MDR in the chemoresistance and tumor propagation of uveal melanoma. Besides, nothing has ever been reported about the possible contribution of CAM-DR in metastatic uveal melanoma. Here we took advantage of the uveal melanoma cell-line SP6.5. a spindlc-cpithclioid mixed type culture obtained from a primary tumor (17.18) . to gain information on the chemo resistance conferred by the ECM. This cell line proved to be a useful model as it possesses the ability to produce tumor and liver metastasis in nude mice (19) . Due to ihc in vivo infiltrative growth of uveal melanoma, these cancer cells inevitably interact with basement membrane proteins (such as laminin and type IV collagen) at the site of intra-and extravasation. Besides. SP6.5 cells were shown to secrete FN in vitro and in vivo and to organize it in complex net works (17.18) . In the present study, we investigated whether individual components from the ECM may affect cell survival and/or cell death induced by cDDP. a cytotoxic agent extensively used in clinic for the treatment of several forms of cancers, including uveal melanoma, on the SP6.5 uveal melanoma cell-line. We found that several ECM proteins modulate the cDDP-induccd cytotoxicity toward SP6.5 cells and that these proteins are present in the tumor environment of uveal melanoma at primary and metastatic sites.
Materials and methods
This study was conducted in accordance with our institutional guidelines and the Declaration of Helsinki, and the protocols approved by the institution's Committee for the Protection of Human Subjects.
Cell culture anil reagents. All reagents were purchased from Sigma-Aldrich (Oakville, ON, Canada), unless otherwise specified. The uveal melanoma cell line SP6.5 was maintained in Dulbccco's modified Eagle's medium (DMEM) with penicillin-streptomycin-gluiamin (additives; Invilrogcn. Burlington, ON. Canada), supplemented with 5'
: /c fetal bovine serum (FBS; Invitrogen) and kept under 5% CO : al 37°C.
The ECM component fibroncclin (FN) was prepared from human plasma as previously described (20) and diluted in a solution of 33% glycerol in phosphate-buffered saline (PBS) and stored at -80°C prior coaling of the culture plates. Gel analysis indicated that the purified FN was of the appropriate molecular mass and showed no proteolytic degradation.
Human placental collagen type IV and mouse laminin I were purchased from Trevigen (Gailhcrsburg. Ml). USA) and diluted in PBS (pH 7.4) prior to their storage at -20°C. cDDP was diluted in PBS (slock solution 2 mM) and kept frozen at -70"C. The day of the experiment, an aliquot was thawed and appropriately diluted in PBS. The remaining slock solution was discarded.
Indirect immunofluorescence assays and nuclear DAPl staining. Fresh samples of tumor tissues obtained from 3 posterior uveal melanomas at enucleation (T88. T89 and T95) and from metastatic post-mortem liver sections (MH80) were embedded in OCT (Optimal Culling Temperature) compound (Tissue-Tek. Bayers Canada. Elobicokc, ON. Canada), frozen in liquid nitrogen and then stored at -70°C until used. An indirect immunofluorescence assay was performed on acetone-fixed (10 min at -20"C) cryosections (5 \im thick) of frozen tissues as previously reported (21 
Results

Fibroncctin. type IV collagen and laminin arc present in the ECM-rich environment of the uveal melanoma cells.
To determine the composition of Ihe ECM that forms the dense uveal melanoma stroma, either directly produced within the tumor or deposited from the plasma, immunofluorescence analyses were conducted on human primary ocular melanomas isolated from three different patients (T88. T89. and T95) or on a liver section from a patient that developed liver metastases (MH80). As expected, a strong labeling for the various ECM components that arc usually found in the basement membrane (CIV. red: LM. green) were identified around tumor-associated blood vessels (Fig. I) . There are. however, sonic differences in the relative expression of ECM proteins between the three primary tumors and the liver metastasis. Indeed. FN. CIV. and LM staining throughout the three primary tumors (T88. T89 and T95) exhibited a high hetero geneity from diffuse, weak, to strong staining. Both T88 and T95 yielded a strong but diffuse FN staining all over the entire section (Fig. la anil c) . whereas it was localized primarily around vascular structures in the T89 tissue (Fig. lb) . All three primary tumors stained strongly for CIV all over the tissue section and especially around vascular structures (Fig. le-g ). LM staining was strong but localized around vessels for the T88 and T89 tumor sections (Fig. I i and j) . LM staining is comparable to that of FN for the T95 specimen in terra Of intensity and localization (Fig. Ik) . On the other hand, the presence of extensive and strong staining for FN, CIV. and LM were seen throughout the metastatic sections (Fig. Id. h and I ) compared to the primary tumors specimens.
To evaluate whether the ECM proteins are closely associated with the tumor cells, lumor tissues were labeled with the HMB45 antibody, a specific marker for melanoma cells (24) . Double-staining of both melanoma cells (in red in Fig. Im-t) and CIV (in green in Fig. I m-p) provided evidence that neither arc closely associated (Fig. Im-o) . while the liver metastatic tissue shows a high degree of CIV expression in areas where HMB45-positive cells arc embedded (Fig. Ip) . A very similar staining pattern was also observed with LM, high level ol' LM expression being found around lumor cells in the metastatic loci from the liver tumor (Fig. It) but not from primary tumors (Fig. lq-s) . We therefore concluded that in vivo, FN. CIV and LM are present in the ECM-rich microenvironment that surrounds the uveal melanoma cells. with an enrichment of matrices in the immediate vicinity of the cancer cells from the metastatic liver sections.
Binding qfSP6.5 cells to ECM proteins FN, CIV, and to LM is primarily mediated through fil integrins.
It is well established that ECM elicits a wide variety of cell signaling pathways and that most of these effects arc primarily mediated by membrane-bound integrins (25) . Cellular binding lo FN. CIV. and to LM can be mediated by several intcgrin receptors, most from the Bl intcgrin family (26) . Studies have suggested that the binding of I'll integrins lo ECM in some solid lumor types lead to an apoptosis-protccting effect (27.28) . In order to determine whether Bl integrins promote adhesion of uveal melanoma to these various ECM components, inhibition of adhesion assays were performed in vitro. For this purpose SP6.5 cells were preincubated with a blocking antibody (P4CI0) raised against the Bl subunii. and then plated on FN. CIV. and LM-coaled culture plates. Cells unexposed to the P4CIÜ antibody were also used as a control. As shown in Fig. 2A . while a low concentration of P4C10 (I ug/ml) inhibited the adhesion lo both FN and LM by 50-and 70%. respectively, il virtually abolished the adhesion lo CIV. The use of a higher concentration of the Bl blocking antibody (either 10 or 25 ug) inhibited up to 75% adhesion lo FN and totally abolished adhesion to both CIV and LM. Indeed. SP6.5 cells were shown to express high levels of membrane bound Bl subunit through flow cytometry (Fig. 2B) . The remaining 25% of cells attached to FN when the P4C10 antibody is used can be explained by the fact that adhesion to FN might also be mediated through non-61 integrins. As binding to both FN and LM can also be mediated through the ctvB3 integrin, we repeated the same experiment using a blocking antibody (LM609) directed against this integrin. As this receptor through How cytometry (Fig. 2B) although to a lower level than that observed for the Bl subunit. Wc therefore conclude that both the PI integrin subunit and the uvB3 integrin are expressed in the SP6.5 uveal melanoma cell line and that adhesion ol' these cells to FN, CIV, and LM is primarily dictated by Bl integrins.
Effect of ECM proteins on the distribution of cell cycle phases.
Interactions between cells and the ECM components exert profound effects on cell survival, growth, and differentiation (29 Cell adhesion-mediated drug resistance in uveal melanoma SP6.5 cells. Recent studies have indicated that lumor cell adhesion lo a specific matrix is capable of modulating resistance to drug-induced apopiosis in some lypc of cancer cells, such as myelomas, glioma and small cell lung cancer cells (I i. 16.28). We examined whether the same is true for uveal melanoma cells. Fig. 2 shows that SP6.5 cells attach to FN. CIV and to LM and as judged by cytotoxicity assays and by morphologic changes (Fig. 3) , the addition of the chemotherapeutic agent cDDP induced a concentration-dependent increase in SP6.5 cell death. In order lo lest the hypothesis that ECM proteins might protect uveal melanoma cells from chemotherapy-induced apopiosis. wc treated SP6.5 cells with cDDP in the presence or absence of various ECM proteins and performed an apopiosis assay. Cells were prc-altachcd lo FN. CIV. LM or BSA coaled dishes for 24 h and treated with 0. 10 or 25 |iM cDDP for 24 h. Fig. 4 shows that in Ihe absence of cDDP. SP6.5 cells (which corresponded lo approximately 8% ol' the cells plated on BSA coaled euliure plales). were partially but significantly protected from apopiosis when cultured on FN. CIV or LM coated plates (25-, 25-, and 59% reduction in the relative number of apoptotic cells, respectively). These ECM components also conferred a significant protective effect lo SP6. and 17% reduction of apoptotic cells exposed to 25 U.M cDDP on FN, CIV. and LM. respectively). As expected. cDDP forced a dosc-dependcnl increase in apopiosis. Indeed, ihe proportion of apoptotic cells measured in SP6.5 cells attached on BSA. which did not protect cells from cDDP- induced apopiosis. increased from approximately 8% in the absence of cDDP to 29% and 51% when exposed to I0-and 25 uM cDDP. respectively. These results suggest that matrix attachment provides a protection against cDDP induccdapoptosis in uveal melanoma cells and attachment-induced survival signaling may take place when uveal melanoma cells are adhered on the ECM matrix componenis FN. CIV and LM.
Discussion
Primary tumor growth and rale of progression toward metastasis arc key determinants in the clinical outcome of patients with cancer. It is now well established that tumor progression requires a continually evolving network of interactions between neoplastic cells and the ECM, which, depending on its context, can actively regulate cellular processes such as growth, death, adhesion, migration, invasion, gene expression, and differentiation (30) . It is well documented that metastatic uveal melanoma arc highly resistant to existing chemotherapy. Because the interaction of tumor cells with the ECM is a prerequisite for tumor progression, we hypothesized that the presence of ECM components in the environment of uveal melanoma cells could explain in part the cell's resistance toward chcmothcrapeutic agents. This study showed that uveal melanoma cells in vivo are surrounded by a stroma of ECM at both primary and secondary metastatic sites. Furthermore, we demonstrated through apopiosis assays, thai SP6.5 cells in direct contact with immobilized FN. CIV and LM are less sensitive to apopiosis induced by cisplatin treatment.
Thus far. the cxacl nature and function of ECM deposition in uveal melanoma has nol been elucidated (31) . The morpho logical properties and functional implications of the ECM pattern of formation in uveal melanoma have been extensively discussed in the context of the existence of blood-conducting channels lined by melanoma cells accompanied by the deposition of ECM components and their essential importance for tumor growth and metastasis. Until now. very little has been reported in the literature concerning the implication of ECM in the context of cell survival after chemotherapy in uveal melanoma. The distribution of the various ECM components in uveal melanoma as reported in the present study seems to be heterogeneous between different tumors, but also within the tumor itself. These observations correlate with those of other studies (32) . However, and despite the results presented hereby, il remains unknown whether the ECM components arc deposited by stromal or uveal melanoma cells, or both.
Many chcmothcrapeutic drugs, like cisplatin, contribute to anti-tumor activity by inducing apopiosis (33) . The importance of understanding the role of ECM and ils interaction with tumor cells has been further emphasized by numerous studies showing that deposition of malrix components and their interaction with nearby cells are of first importance in tumor progression (34) . Most studies on multidrug resistance have primarily focused on isolated cancer cells with little consideration being given to the extracellular milieu (9) . In this regard, we hypothesized thai ECM proteins, such as FN. CIV and LM, which are secreted in the immediate environment of uveal melanoma cells in vivo, may protect these tumor cells from the apoplolic death induced by chemotherapeutic stresses. We demonstrated the presence of these components in the area surrounding the tumor cells, suggesting that they could influence the way these cells respond to chemotherapy. /'/; vitro, the binding of SP6.5 uveal melanoma cells to FN. CIV and to LM reduced the cytotoxicity of the chcmoiherapculic agents cisplatin. This may explain at least in part the inefficiency of cDDP in the treatment of patients with uveal melanoma that progressed to liver metastasis (35) , the median survival rale being extended of only a few months at the most (4.8). Despite their anchorageindependence (17) . binding of SP6.5 cells to ECM proteins FN, CIV and LM clearly conferred an increased protection toward chemotherapy-induced apopiosis.
Intcgrins regulate many intracellular signaling pathways including tyrosine phosphorylation and inositol lipid metabolism that arc central to regulation of essential effectors of apopiosis (9) . Il is well known that inlegrin-mediated cell attachment protects normal mammary epithelial cells from apopiosis (13) . and the mechanisms underlying integrinmedialcd survival signaling have started to become uncovered. It is less clear, however, what role intcgrin signaling has in the regulation of cell survival and apoptosis in uveal melanoma cells. Bl intcgrins mediate cell-ECM or cell-cell interactions and can transmil multiple regulatory signals (5,9.11,28,36) . Bl integrins arc essential for normal development, and disruption of the cell-matrix interaction causes apoptosis of normal cells, identifying Bl-integrins as survival factors. Recently, the role of BI-integrins in chemolherapeutic druginduced apopiosis has been examined (36). Zhang el al (36) showed that ovcrcxpression of Bl intcgrins confers resistance to apoptosis in hepatoma cells via a MAP-kinase dependent pathway and this BI-intcgrin mediated signaling from the ECM tp hepatoma cells may contribute to chemotherapy resistance.
The enhanced cell survival conferred by the ECM proteins FN, CIV and LM against drug-induced apoptosis in uveal melanoma cells could be mediated by the Bl integrins. as ligand recognition by some members among this family of receptors was shown to inhibit apoptosis in numerous studies (I 1,27.28.37). Indeed, adhesion of small cell lung cancer cells in vivo to ECM that includes FN, LM and CIV was reported to confer resistance to apoptosis induced by ctoposide. cDDP and doxorubicin. This resistance was shown to depend on Bl integrins as il was completely abrogated by a function-blocking Bl intcgrin antibody (28) . Through the use of adhesion assays, we demonstrated that SP6.5 cells use primarily Bl intcgrins to attach to FN, CIV and LM. Based on these results and on the previous finding thai CAM-DR is primarily a Bl inlegrin-mediated process (I 1.27.28.37). we speculated that SP6.5 cellular resistance toward cDDP is similarly mediated by Bl intcgrins. Further more, SP6.5 cells use to a lesser extent the avB3 iniegrin in order to bind FN ( Fig. 2A) . This intcgrin is critical for the skin melanoma aggressive behavior and also plays a role in reducing apopiosis following interaction of these cancer cells to endogenous ligands such as proteolyzed collagens (12, (38) (39) (40) . At this point, il is not known whether uvB3 protects cells from exogenous insults such as chcmothcrapeutic agents.
It has been well documented that progression through the G, phase of the cell cycle by mammalian cells requires growth factors-and ECM components-induced signal transduction. In eukaryotes, cell proliferation is regulated by external signals, such as the availability of growth factors and nutrients and by internal signals, such as those sensing cellular integrity (41) . Culturing SP6.5 cells on FN. CIV. LM and BSA caused an accumulation of cells at the G, checkpoint significantly different from that obtained when SP6.5 cells arc grown in the presence of mitogens (FBS condition) with a negligible amount of cell death. These results suggest that survival signaling is primarily dictated by the substrate on which SP6.5 cells arc attached, a process clearly distinct from the mitogens induced cell survival that is typical of cells grown in FBScontaining culture medium. The significantly higher proportion of SP6.5 cells in S-phasc on CIV-and LM-coated wells indicates that these matrices arc more permissive for DNA synthesis than FN or BSA. As in the case of cellular stresses created by the lack of mitogens, damage to cellular components (such as DNA damage following cisplatin treatment) activate a checkpoint that arrests the cells in G,; this withdrawal from the cell cycle might be temporary or permanent (41) . It is likely that the combination of both stresses (the lack of mitogens and the DNA damaging agent cDDP) will alter more deeply the ability of the SP6.5 cells to progress through the cell cycle. In such instance, cell's attachment to ECM components like FN. CIV and LM may somehow contribute to weaken these stress factors as these components provide a survival advantage to the cell (as suggested by the results from Fig. 4) .
The results presented in this study highlight a possible function for CAM-DR in the resistance of uveal melanoma cells against chemotherapy. The evidence for the involvement ol' CAM-DR, following its discovery in multiple myeloma cell lines, has been found in a large number of other human cell types (37) . In recent years, our understanding of the tumor microenvironment has led to the suggestion that the targets of therapy should include, along with the tumor cell, the microenvironment that sustain the cell itself (27) . The implication of the CAM-DR mechanism in resistance to drug-induced death in uveal melanoma and ultimately the identification of the molecular mechanisms of action of this phenomenon offers the potential of providing novel therapeutic targets to improve the response to chemotherapy and the impact on survival in cancer patients.
